Neuroprotective efficacy of YM872, an α-amino-3-hydroxy-5- methylisoxazole-4-propionic acid receptor antagonist, after permanent middle cerebral artery occlusion in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 2, 1998, Pages 559-566

  Takahashi, Masayasu ^a   Ni, Jian Wei ^a   Kawasaki Yatsugi, Sachiko ^a   Toya, Takashi ^a   Ichiki, Chikako ^a   Yatsugi, Shin Ichi ^a   Koshiya, Kazuo ^a   Shimizu Sasamata, Masao ^a   Yamaguchi, Tokio ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

[1,2,3,4 TETRAHYDRO 7 (1H IMIDAZOL 1 YL) 6 NITRO 2,3 DIOXO 1 QUINOXALINYL]ACETIC ACID; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL ARTERIES; EXCITATORY AMINO ACID ANTAGONISTS; IMIDAZOLES; MALE; MOTOR ACTIVITY; QUINOXALINES; RATS; RATS, INBRED F344; RECEPTORS, AMPA;

EID: 0032465471     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL and Bartkowski H (1986) Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke 17:472-476.
2. DeGraba TJ, Ostrow PT and Grotta JC (1993) Threshold of calcium disturbances after focal cerebral ischemia in rats. Implications of the window of therapeutic opportunity. Stroke 24:1212-1217.
3. Gill R (1994) The pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischemia. Cerebrovasc Brain Metab Rev 6:225-256.
4. Gill R, Nordholm L and Lodge D (1992) The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model. Brain Res 580:35-43.
5. Graham DI (1988) Focal cerebral infarction. J Cereb Blood Flow Metab 8:769-773.
6. Graham SH, Chen J, Lan JQ and Simon RP (1996) A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia. J Pharmacol Exp Ther 276:1-4.
7. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252: 851-853.
8. Kohara A, Okada M, Ohno K, Sakamoto S, Shishikura J, Inami H, Shimizu-Sasamata M and Yamaguchi T (1996) In vitro characterization of YM872: A selective, potent and highly water-soluble AMPA receptor antagonist. Soc Neurosci Abst 22:1528.
9. 2+ homeostasis. Prog Neurobiol 37:255-285.
10. Nakaki T, Saito M, Nakadate T, Tokunaga Y and Kalo R (1981) Acute physical dependence induced by continuous intravenous infusion of morphine or meperidine in the rat. Psychopharmacology 73:215-218.
11. Nedergaard M (1988) Mechanisms of brain damage in focal cerebral ischemia. Acta Neurol Scand 77:81-101.
12. Nurse S and Corbett D (1996) Neuroprotection after several days of mild, drug-induced hypothermia. J Cereb Blood Flow Metab 16:474-480.
13. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates, 2nd ed, Academic Press, London.
14. Pulsinelli W (1992) Pathophysiology of acute ischemic stroke. Lancet 1:533-536.
15. Shimizu-Sasamata M, Kawasaki-Yatsugi S, Okada M, Sakamoto S, Yatsugi S, Togami J, Hatanaka K, Ohmori J, Koshiya K, Usuda S and Murase K (1996) YM90K: Pharmacological characterization as a selective and potent α-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist. J Pharmacol Exp Ther 276:84-92.
16. Shintani F, Kanba S, Nakaki T, Nibuya M, Kinoshita N, Suzuki E, Yagi G, Kato R and Asai M (1993) Interleukin-1β augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J Neurosci 13:3574-3581.
17. Shiraishi K, Sharp FR and Simon RP (1989) Sequential metabolic changes in rat brain following middle cerebral artery occlusion: a 2-deoxyglucose study. J Cereb Blood Flow Metab 9:765-773.
18. Siesjö BK (1981) Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab 1:155-185.
19. Siesjö BK and Bengtsson F (1989) Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: A unifying hypothesis. J Cereb Blood Flow Metab 9:127-140.
20. Takahashi M, Ni JW, Kawasaki-Yatsugi S, Toya T, Yatsugi S, Shimizu-Sasamata M, Koshiya K, Shishikura J, Sakamoto S and Yamaguchi T (1998) YM872, a novel selective α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, reduces brain damage after permanent focal cerebral ischemia in cats. J Pharmacol Exp Ther 284:467-473.
21. Takasago T, Peters EE, Graham DI, Masayasu H and Macrae IM (1997) Neuroprotective efficacy of ebselen, an anti-oxidant with anti-inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion. Br J Pharmacol 122:1251-1256.
22. Tamura A, Graham DI, McCulloch J and Teasdale GM (1981) Focal cerebral ischemia in the rat: Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1:53-60.
23. Verdoorn TA, Burnashev N, Monyer H, Seeburg PH and Sakmann B (1991) Structural determinants of ion flow through recombinant glutamate receptor channels. Science 252:1715-1718.
24. Wong LA and Kemp JA (1991) Sites for antagonism on the N-methyl-D-aspartate receptor channel complex. Annu Rev Pharmacol Toxicol 31:401-425.
25. Xue D, Huang ZG, Smith KE and Buchan AM (1992) Immediate or delayed mild hypothermia prevents focal cerebral infarction. Brain Res 587:66-72.
26. Xue D, Huang ZG, Barnes K, Lesiuk HJ, Smith KE and Buchan AM (1994) Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. J Cereb Blood Flow Metab 14:251-261.
27. Yatsugi S, Takahashi M, Kawasaki-Yatsugi S, Koshiya K, Sakamoto S, Uematsu D and Shimizu-Sasamata M (1996) Neuroprotective effect of YM90K, a novel AMPA/ kainate receptor antagonist, in focal cerebral ischemia in cats. J Cereb Blood Flow Metab 16:959-966.